Home / Health / The strains of the coronavirus that first appeared in India were in the United States. This is something you should know.

The strains of the coronavirus that first appeared in India were in the United States. This is something you should know.



The Indian devastating corona virus strain B.167 has now arrived in the United States. Experts say it is unlikely to cause much harm due to the high rates of vaccination and because the health care system is not under stress. But with the virus that defies expectations and the strain spreading to hundreds of thousands of Indians every day, researchers are keeping an eye on it.

Here’s what you need to know about the coronavirus strains that originate in India:

What is the variable B.1.167?

It first appeared in India, believed to be involved in the country̵

7;s second wave of COVID-19 harassment. The World Health Organization has been dubbed the It was “worrying variant” last week because of concerns that it might be more contagious and it might be easier to evade existing vaccines.

There are several sublineages of the variables, including B.1.167.1 and B.1.167.2.

Sometimes called “dual mutants.,“Due to the doubling of mutations compared to some earlier SARS-COVI-2 viruses that cause COVID-19, the concern in the first place is that it could be doubly dangerous.” This is not This seems to be the case. Both mutations are no worse than having one, ”said Dr. Charles Chew, professor and expert in viral genome at the University of California, San Francisco.

Is it in the US?

Yes, the United States is one of the 49 counties where the species has spread. But so far it has been low.As of May 8, variable B.1.167 accounted for 3% of all COVID-19 cases in the United States, according to the Centers for Disease Control and Prevention. It appears to be competing with the B.1.1.7 variant for the first time in the UK, at least in India. Krutika Kuppalli, a fellow of the American Association of Infectious Diseases and an infectious disease specialist at the University of Medicine. South Carolina’s B.1.1.7 accounts for 72 percent of COVID-19 infections in the United States, according to CDC data released Wednesday.

Family members hold an urn containing ashes from the remains of a COVID-19 victim at a crematorium on the outskirts of Bengaluru, India, on May 12, 2021.

Family members hold an urn containing ashes from the remains of a COVID-19 victim at a crematorium on the outskirts of Bengaluru, India, on May 12, 2021.

Is the variant more contagious?

This variant is very new, so there isn’t much solid and truthful information. Of course, it is spreading rapidly in India, however, that country has received only 11% of the vaccinations, most of whom received their first vaccinations. Laboratory studies seem to indicate that this is no more contagious.

One study looking at how well the variant was able to enter cells found it was no better than other types of SARS-CoV-2, Chiu said.

Will it get a foothold in the US?

Impossible to know But with the high vaccination rates here it doesn’t seem to replace the current dominant B.1.1.7 strain, nearly 47% of people in the United States are partially vaccinated. New species to replace “We have a high level of community immunity, so even here we are. But there’s less room to grow, ”said Dr. Monica Gandhi, an infectious disease specialist at the University of California, San Francisco.

Are current US vaccines effective with variables?

They seem to work Only one in seven blood samples from previously infected or vaccinated people were effective with the B.1.167 variable compared to the original virus. But it is believed to be sufficient to prevent it, especially from severe disease and hospitalization, said Mehul Suthar, a virologist at Emory University, who co-authored a paper on the variant published May 10, but also. Not peer reviewed

“Despite the decline, all vaccine blood samples and nearly 80% of blood samples from people who have previously been infected have maintained the ability to block this Indian variant,” Suthar said.

Health workers water patients at BKC Jumbo Field Hospital, one of the largest COVID-19 facilities in Mumbai, India, Thursday, May 6, 2021.

Health workers water patients at BKC Jumbo Field Hospital, one of the largest COVID-19 facilities in Mumbai, India, Thursday, May 6, 2021.

“We have no reason to believe the vaccine response to this strain is problematic,” added Dr. Eric Topol, professor of molecular medicine at the Scripps Research Institute in La Jolla, California. “This has been evaluated in Israel and elsewhere, and the mutations do not seem to be able to evade vaccines.”

Additionally, studies have shown that the vaccine is effective against two of the main mutations that this variant has. “So it is reasonable to conclude that vaccines are likely to be effective against variables,” Chiu said.

Is the person recovering from COVID-19 protected B.1.167?

Not as good as it could be if vaccinated In laboratory tests, the vaccine provides a much better overall immune response, “so a person recovering may not have the same protection as the person who was vaccinated,” said Shiu.

However, he notes that what happens in a laboratory is not necessarily related to what is going on inside people. “We are predicting,” he said.

A woman was vaccinated against COVID-19 in a car at a vaccination center in Mumbai, India, on May 4, 2021. COVID-19 infection and deaths are on the rise in India without the end of Crisis.

A woman was vaccinated against COVID-19 in a car at a vaccination center in Mumbai, India, on May 4, 2021. COVID-19 infection and deaths are on the rise in India without the end of Crisis.

If the vaccine works, why are things so bad in India?

Because India’s vaccination rate is very low. Only about 10% of India’s 1.3 billion people receive at least one dose of the vaccine, and only 2.8% are fully immunized. When the person who received one dose of vaccine there “They only had a small number of infections,” Gandhi said.

The vaccine’s reduced efficacy means more people will need to be vaccinated to provide the same level of population protection, Suthar said.

“It underscores the need to increase vaccination rates and how vaccines can help reduce the number of infections and eliminate what is currently dire in India,” said Suthar.

India’s current problems are far too good to happen.

The high-density urban areas simplify diffusion, while the lack of infrastructure in rural areas makes it difficult to monitor the epidemic and patient care.

“After they overcome the first wave of infections (last year), there are false tales that India may have overcome COVID,” Guppalli said.

That sentiment encourages governments to ease efforts such as hiding their aloofs and avoiding crowds, ”she said.“ When you have eased public health measures with population density and socioeconomic issues, it is ready for development. Of the spread of these things, infection “

Another major challenge is the spread of misinformation through social media, mostly about folk remedies to eliminate COVID-19, said Kasisomayajula Viswanath, Harvard professor of health communications at the TH Chan School of Public Health.

“There is a reliance on these kinds of folk remedies that are being passed on,” he said in a media claim, refusing to cite specific details, as he did not want the rumors.

Viswanath said 170 million Indians had already been vaccinated once, but only 13 million were fully immunized out of the country, 1.3 billion even if there was enough vaccine. But still don’t have But it will take a long time before someone is vaccinated enough to help reduce infection rates, he said.

Contact Elizabeth Weise at eweise@usatoday.com and Karen Weintraub at kweintraub@usatoday.com.

Patient health and safety coverage at USA TODAY is partially possible, funded by the Masimo Foundation for Ethics, Innovation and Competition in Healthcare.The Masimo Foundation does not provide editorial feedback.

This article originally appeared in USA TODAY: Coronavirus variant B.1.167 first appeared in India, now in the US.


Source link